Literature DB >> 17135218

Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve-inferior vena cava isthmus? Results of a multicentre randomised controlled trial.

Dhiraj Gupta1, Mark J Earley, Guy A Haywood, Laura Richmond, Melissa Fitzgerald, Pipin Kojodjojo, Simon C Sporton, Nicholas S Peters, Paul Broadhurst, Richard J Schilling.   

Abstract

OBJECTIVE: To see if strategy of ablating the tricuspid annulus-inferior vena cava isthmus (TV-IVC) is superior to electrical cardioversion to prevent recurrences in patients with coarse atrial fibrillation.
DESIGN: Prospective randomised controlled multicentre study.
SETTING: Four tertiary referral hospitals in the UK. PATIENTS: 57 patients with persistent coarse atrial fibrillation (irregular P waves > or =0.15 mV in > or =1 ECG lead).
INTERVENTIONS: Patients were randomised to receive external cardioversion (group A, n = 30) or TV-IVC ablation +/- DC cardioversion (group B, n = 27). MAIN OUTCOME MEASURES: Cardiac rhythm, scores on quality of life and symptom questionnaires were assessed at 4, 16 and 52 weeks after the procedure.
RESULTS: 20 (67%) patients in group A and 19 (70%) patients in group B were in sinus rhythm immediately after their index procedure. At 4, 16 and 52 weeks, the number of patients in sinus rhythm were 5, 3 and 2 in group A and 3, 3 and 1 in group B (p = NS). The quality of life and symptom questionnaire scores were similar in the two groups at each period of follow-up, although they were significantly better for sinus rhythm than for atrial fibrillation at each follow-up visit.
CONCLUSIONS: As a first-line strategy, TV-IVC ablation offers no advantages over direct current cardioversion for the management of coarse atrial fibrillation.

Entities:  

Mesh:

Year:  2006        PMID: 17135218      PMCID: PMC1955209          DOI: 10.1136/hrt.2006.102061

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  Ablation of isthmus dependent atrial flutter: when to call for the next patient.

Authors:  Mevan Wijetunga; Alex Gonzaga; S Adam Strickberger
Journal:  Pacing Clin Electrophysiol       Date:  2004-10       Impact factor: 1.976

3.  Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

Authors:  S E Coplen; E M Antman; J A Berlin; P Hewitt; T C Chalmers
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

4.  Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.

Authors:  G Opolski; J Stanisławska; A Górecki; G Swiecicka; A Torbicki; T Kraska
Journal:  Clin Cardiol       Date:  1997-04       Impact factor: 2.882

5.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation.

Authors:  I C Van Gelder; H J Crijns; R G Tieleman; J Brügemann; P J De Kam; A T Gosselink; F W Verheugt; K I Lie
Journal:  Arch Intern Med       Date:  1996 Dec 9-23

Review 6.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

7.  Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Authors:  Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

8.  Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

Authors:  Vincent E Hagens; Adelita V Ranchor; Eric Van Sonderen; Hans A Bosker; Otto Kamp; Jan G P Tijssen; J Herre Kingma; Harry J G M Crijns; Isabelle C Van Gelder
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

9.  Atrial fibrillation: mechanistic insights from biatrial (and triatrial) mapping.

Authors:  Robert Lemery
Journal:  J Cardiovasc Electrophysiol       Date:  2003-11

10.  Electrocardiographic and electrophysiological characteristics of atrial fibrillation organized into atrial flutter by oral administration of class I antiarrhythmic agents.

Authors:  Kazuko Ohmura; Yoshinori Kobayashi; Yasushi Miyauchi; Yasumi Endoh; Hirotsugu Atarashi; Takao Katoh; Teruo Takano
Journal:  Pacing Clin Electrophysiol       Date:  2003-03       Impact factor: 1.976

View more
  1 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.